click below
click below
Normal Size Small Size show me how
GI Disorders
Activators & Inhibitors
| Type | Chemical | Released by / Trigger | Primary gastric effects | Primary target(s) |
|---|---|---|---|---|
| Activator | Acetylcholine (ACh) | sight, smell, taste, ingestion of food | ↑ Histamine | ECL cells |
| Activator | Acetylcholine (ACh) | sight, smell, taste, ingestion of food | ↑ H+ release | Parietal cells |
| Activator | Acetylcholine (ACh) | sight, smell, taste, ingestion of food | ↓ Somatostatin | D-cells |
| Activator | Gastrin | Dietary peptides; GRP receptor stimulation | ↑ Histamine | ECL cells |
| Activator | Gastrin | Dietary peptides; GRP receptor stimulation | ↑ H+ release | Parietal cells |
| Activator | Histamine | ACh or Gastrin | ↑ H+ release | Parietal cells |
| Inhibitor | Prostaglandins (PGEs) | fatty acids (e.g., arachidonic acid) | ↓ H+ release | Parietal cells |
| Inhibitor | Prostaglandins (PGEs) | fatty acids (e.g., arachidonic acid) | ↑ mucus production | Mucous cells |
| Inhibitor | Somatostatin | Luminal acid | ↓ H+ release | Parietal cells |
| Inhibitor | Somatostatin | Luminal acid | ↓ gastrin | G-cells |
| Inhibitor | Somatostatin | Luminal acid | ↓ Histamine | ECL cells |
| Inhibitor | Somatostatin | Luminal acid | ↓ pepsin | Chief cells |
| Inhibitor | Somatostatin | Luminal acid | ↑ mucus secretion | Mucous neck |
| Pathophysiology | H. pylori urease | Infection of gastric mucosa | ↓ D-cell SST; ↑ Gastrin (hypergastrinemia) | D cells (inhibition), G cells (disinhibition) |
| Pathophysiology | Gastrin cascade | D-cell suppression | ↑ ECL histamine → ↑ Parietal H+ | ECL → Parietal |
| Pathophysiology | NSAIDs → COX inhibition | NSAID therapy | ↓ Prostaglandins → ↓ mucus/HCO3-; loss of parietal inhibition | Mucous cells; Parietal cells |
| Drug | H2 antagonists | Drug administration | Block H2 → ↓ cAMP → ↓ H+ (works early in pathway) | Parietal H2 |
| Drug | PPIs | Prodrug activation in parietal cell | Irreversibly inhibit H+/K+-ATPase → ↓↓ H+ (works later in pathway) | Parietal proton pump |
| Drug | PCAB | Drug administration | Reversibly competes with K+ at H+/K+-ATPase → ↓ H+ | Parietal proton pump (K+ site) |
| Drug | Antacids | Drug administration | Neutralize luminal H+ → ↑ pH | Luminal H+ (non-cellular) |
| Drug | Bismuth | Drug administration | Coat mucosa; protect ulcers; H. pylori inhibition | Mucosal surface / bacterial factors |
| Drug | Sucralfate | Drug administration | Coat mucosa; protect ulcers | Mucosal surface / bacterial factors |
| Neural node | Chemoreceptor Trigger Zone (CTZ) – D2, 5HT3, CB1 | Circulating emetogens/toxins | Initiates emetic signaling (central) | Vomiting center |
| Neural node | Vomiting Center – H1, M1, NK1, 5HT3 | Inputs from CTZ, vestibular, GI | Coordinates motor pattern of emesis | Brainstem nuclei / GI efferents |
| Neural node | Vestibular system – H1, M1 | Motion/inner ear stimuli | Activates emesis (motion sickness) | Vomiting center |
| Neural node | GI tract afferents – 5HT3, D2, M1, H1, CB1/2 | GI irritation, chemotherapy | Serotonin from enterochromaffin cells stimulates vagal afferents | CTZ / Vomiting center |